By: dfitzgerald
This white paper provides an overview of the systemic and individual payer-based barriers to full implementation of pharmacist prescribing…
This is a roadmap for state advocates, policymakers, and other stakeholders to understand how best to achieve legislation, state…
The U.S. Food and Drug Administration (FDA) announced new changes to the mifepristone Risk Evaluation and Mitigation Strategy (REMS)…